List of Excipients in API netupitant and palonosetron
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing netupitant and palonosetron
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Helsinn Therapeutics (US) Inc | AKYNZEO | netupitant and palonosetron | 69639-101 | BUTYLATED HYDROXYANISOLE | 2035-09-25 |
Helsinn Therapeutics (US) Inc | AKYNZEO | netupitant and palonosetron | 69639-101 | CAPRYLIC/CAPRIC MONO/DIGLYCERIDES | 2035-09-25 |
Helsinn Therapeutics (US) Inc | AKYNZEO | netupitant and palonosetron | 69639-101 | CELLULOSE, MICROCRYSTALLINE | 2035-09-25 |
Helsinn Therapeutics (US) Inc | AKYNZEO | netupitant and palonosetron | 69639-101 | CROSCARMELLOSE SODIUM | 2035-09-25 |
Helsinn Therapeutics (US) Inc | AKYNZEO | netupitant and palonosetron | 69639-101 | FERRIC OXIDE RED | 2035-09-25 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for netupitant and palonosetron
Excipient focus: BUTYLATED HYDROXYANISOLE
netupitant and palonosetron drug variants containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
netupitant and palonosetron drug variants containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
netupitant and palonosetron drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
netupitant and palonosetron drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
netupitant and palonosetron drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
netupitant and palonosetron drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
netupitant and palonosetron drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
netupitant and palonosetron drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
netupitant and palonosetron drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-3 DIOLEATE
netupitant and palonosetron drug variants containing POLYGLYCERYL-3 DIOLEATE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing POLYGLYCERYL-3 DIOLEATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
netupitant and palonosetron drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
netupitant and palonosetron drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
netupitant and palonosetron drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
netupitant and palonosetron drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE LAURATE
netupitant and palonosetron drug variants containing SUCROSE LAURATE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing SUCROSE LAURATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
netupitant and palonosetron drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
netupitant and palonosetron drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Helsinn Therapeutics (US) Inc | netupitant and palonosetron | 69639-101 |
>Company | >Ingredient | >NDC |
netupitant and palonosetron drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.